Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday.
Paulo Dybala is expected to undergo season-ending surgery next week.As reported by Il Messaggero, the Argentine will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback